Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Health Discovery Corp. (HDVY : OTCBB)

• Company Description    Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. The principal healthcare market for its pattern recognition technology and biomarker discoveries is medical diagnostics, particularly the field of molecular diagnostics. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $0.03 Daily Weekly Monthly 20 Day Moving Average: 311,391 shares Shares Outstanding: 401.58 (millions) Market Capitalization: $13.73 (millions) Beta: 2.81 52 Week High: $0.43 52 Week Low: $0.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.47% -12.91% 12 Week -30.06% -21.40% Year To Date 36.80% 67.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2002 Summit Blvd NE Suite 300 - Atlanta,GA 30319 USA ph: 404-566-4865 fax: - investor@healthdiscoverycorp.com http://www.healthdiscoverycorp.com

• General Corporate Information    Officers George H. McGovern - Chairman and CEO Marty Delmonte - President; Chief Operating Officer; Principal Fina William F. Fromholzer - Director Colleen M. Hutchinson - Director Edward Morrison - Director Peer Information Health Discovery Corp. (CORR.) Health Discovery Corp. (RSPI) Health Discovery Corp. (CGXP) Health Discovery Corp. (BGEN) Health Discovery Corp. (GTBP) Health Discovery Corp. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 42218R100 SIC: 6794 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/21 Next Expected EPS Date: 05/27/22 Share - Related Items Shares Outstanding: 401.58 Most Recent Split Date: (:1) Beta: 2.81 Market Capitalization: $13.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/27/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - -473.24 Current Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - 0.33 Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - 0.33 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - - 09/30/21 - 0.00 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©